Andrew A. Young

发表

One SPE (August 2003)

Andrew A. Young, 2003 .

One SPE (February 2003)

Andrew A. Young, 2003 .

One SPE (March 2003)

Andrew A. Young, 2003 .

One SPE (April 2003)

Andrew A. Young, 2003 .

One SPE (June 2003)

Andrew A. Young, 2003 .

One SPE (May 2003)

Andrew A. Young, 2003 .

One SPE (October 2002)

Andrew A. Young, 2002 .

One SPE (January 2003)

Andrew A. Young, 2003 .

One SPE (November 2002)

Andrew A. Young, 2002 .

Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice

Andrew A. Young, Ming-Wei Wang, Weiwei Gao, 2010, PloS one.

Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice

Andrew A. Young, Ming-Wei Wang, Weiwei Gao, 2008, PloS one.

Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin

Andrew A. Young, William Vine, T. Rink, 1996 .